Allogenic Vγ9Vδ2 T cell as new potential immunotherapy drug for solid tumor: a case study for cholangiocarcinoma
Mohammed Alnaggar, Yan Xu, Jingxia Li et al. · Journal for ImmunoTherapy of Cancer · 2019 · Case report
Full textCC BY
Surgery
Filters2 filters applied
1 paperQuestions on this topic